Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
18%(2 trials)

Phase Distribution

Ph phase_2
8
38%
Ph not_applicable
4
19%
Ph phase_1
2
10%
Ph phase_4
5
24%
Ph phase_3
2
10%

Phase Distribution

2

Early Stage

8

Mid Stage

7

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
2(9.5%)
Phase 2Efficacy & side effects
8(38.1%)
Phase 3Large-scale testing
2(9.5%)
Phase 4Post-market surveillance
5(23.8%)
N/ANon-phased studies
4(19.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

21

all time

Status Distribution
Completed(11)
Other(10)

Detailed Status

Completed11
unknown9
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (9.5%)
Phase 28 (38.1%)
Phase 32 (9.5%)
Phase 45 (23.8%)
N/A4 (19.0%)

Trials by Status

unknown943%
completed1152%
suspended15%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT03809273Phase 4

Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI

Completed
NCT06656442Phase 3

"The Effect of Trimetazidine on the Clinical Outcome of Acute Ischemic Stroke Patients"

Completed
NCT07074834Not Applicable

Metoprolol and Trimetazidine for Coronary Heart Disease With Angina

Completed
NCT06140953Phase 2

Benefits of Trimetazidine in MASLD Patients

Completed
NCT06459193Phase 1

Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy

Completed
NCT05633563Phase 4

The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed With Wild-Type Transthyretin Cardiac Amyloidosis

Completed
NCT02107144Phase 4

The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease

Completed
NCT05147194Phase 2

The Effects of TMZ on Diabetic Nephropathy

Unknown
NCT04939857Phase 2

Effect of Trimetazidine on Radiotherapy-induced Heart Damage.

Unknown
NCT04511520Not Applicable

Efficacy of Personalized Exercise Program and Trimetazidine in Rehabilitation of Patients After RFA of AF

Completed
NCT03737448Phase 1

TRimetazidine for acUte on Chronic Liver Failure STudy

Suspended
NCT04760821Phase 2

Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19

Unknown
NCT03603249Phase 2

Trimetazidine as an Adjunct to Enhance Clopidogrel Response.

Completed
NCT03273387Phase 2

The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension

Completed
NCT03887013Phase 4

Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease

Unknown
NCT03504202Not Applicable

Effect of Trimetazidine on the Improvement of Coronary Microvascular Dysfunction in Patients With INOCA(Ischemia and no Obstructive Coronary Artery Disease)

Unknown
NCT03715582Phase 3

Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabetes

Unknown
NCT02826616Not Applicable

Effect of Trimetazidine During the Primary PCI on Cardiac Function in Patients With ST-elevation Myocardial Infarction

Unknown
NCT02102672Phase 2

Trimetazidine in Pulmonary Artery Hypertension

Unknown
NCT01696370Phase 2

Trimetazidine Therapy in Hypertrophic Cardiomyopathy

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
21